Is Your MedTech Portfolio Ready for the MDR 2026 Deadline?

At HIPP, one thing is clear from the MDR reality in Europe: the pressure on OEMs is growing fast.

Rising costs, longer approval times, shrinking capacities, and more complex supply chains are slowing down MedTech innovation across the EU – and many manufacturers are now at a turning point.

To help OEMs navigate this landscape, we’ve created a free Whitepaper that breaks down the current MDR situation and shows how integrated Contract Manufacturing can restore speed, stability, and compliance across the entire process chain.

You’ll learn:

• Why MDR compliance is already impacting time-to-market and competitiveness
• How supplier consolidation can cut costs by up to 20 %
• Why validated, audit-proof processes are becoming essential for OEMs
• How end-to-end manufacturing strengthens documentation, traceability, and regulatory readiness
  
  

If you’re looking for clarity on what the MDR means for your development pipeline — and how to stay competitive despite increasing regulatory demands — this Whitepaper will give you the overview you need.